Look, I know I’m not the only one who had a minor panic attack last month when the FDA dropped the hammer. If you’ve been living under a rock or just started your GLP-1 journey, here’s the TL;DR: The agency officially declared the shortage of name-brand Zepbound and Wegovy "resolved." Which, for us regular folks, translates to a massive crackdown on compounding pharmacies. For the last two years, compounders were legally allowed to whip up Tirzepatide and Semaglutide because Big Pharma couldn’t keep up with demand. Now? The music is stopping, and a lot of chairs are being pulled out from under people. I’ve spent the last 72 hours deep in the rabbit hole—reading legal dockets, talking to lab reps, and trying to figure out how to keep my protocol going without paying $1,200 a month out of pocket. Here is the brutal reality, what the ban actually means, and how we might navigate this moving forward. Disclaimer: The following information is for educational and research purposes only. The products discussed are strictly for research purposes only, and not used for human direct consumption. I am not a doctor. Do your own homework. Why This Ban is Different Than the “Scares” Before We’ve seen rumors of this ban for about six months. Usually, a compounding pharmacy would just add a vitamin (like B12 or Glycine) to the vial to bypass the patent, calling it a “customized formula.” The FDA tolerated that for a while. They aren't tolerating it now. The OFA (Outsourcing Facilities Association) lost a big legal battle recently. The courts ruled that as long as the brand-name drugs are on the “FDA Shortage List,” compounders can play. The moment they come off the list? Game over. Both Tirzepatide and Semaglutide are now officially deemed "available." What does this mean for you? Your local compounding pharmacy is probably sending out "We regret to inform you" emails as we speak. They can't legally fill your script anymore. For those of us who found a sustainable, affordable way to manage our metabolic health, this feels like getting rug-pulled by the system.